While CD20 is present in 40% of pre-B acute lymphoblastic leukemia/lymphoblastic lymphoma cases, it is also observed in diffuse large B cell lymphomas (DLBCLs) and large B cell lymphomas, as well as CLL [73,76,77]. This evidence concerns the gene MS4A1 and lymphoblastic lymphoma.